Coronavirus

Health workers and residents and staff of long-term care facilities top the list; tougher decisions lie ahead

Biotech will ask FDA for emergency approval as final results from efficacy trial back up initial claim of vaccine success

HHS Protect data, which influence how pandemic supplies and support are allocated, conflict with state or other federal data, Science has found

On this week’s show: What we’ve learned about keeping schools safe during a pandemic, what triggers the timing of fall leaves, and a book about what nature does when confronted with crisis

Its version of Warp Speed aims not just to stem the COVID-19 pandemic, but to build diplomatic and trade ties

Researchers wonder why lower dose prompted better efficacy in study of vaccine candidate from the University of Oxford and AstraZeneca

Researchers warn secrecy could harm public trust

Sputnik V vaccine still has more than 90% efficacy in second interim analysis

COVID-19 and repeated storms and wildfires have shaped how people perceive risks

AstraZeneca/University of Oxford vaccine uses a chimpanzee virus to deliver coronavirus gene and had better efficacy, 90%, when given as a half dose followed by a full dose

Journalists discuss what it’s like to live the stories they’re reporting

Vaccine successes raise doubts even as planning for first “human challenge” trial continues

“Take Tylenol and suck it up”: side effects show vaccine is working, physicians and researchers say

Early evidence suggests schools can stay open even in the face of significant community spread

Reinfections give scientists clues about how long protection lasts—and how well vaccines might perform

Efficacy trial reaches endpoint and companies plan to soon submit data for emergency use authorizations in the United States and elsewhere